Letter: Katko supports important research into Alzheimer's disease

Letter: Katko supports important research into Alzheimer's disease


Alzheimer’s disease affects 5.7 million Americans, including 400,000 here in New York State. As the sixth leading cause of death and the only one that cannot be prevented, treated or cured, medical and scientific research is essential to bring us closer to a world without Alzheimer’s disease. With this in mind, we commend Rep. John Katko for voting in favor of the Omnibus Appropriations for Fiscal Year 2018, which included a $414 million increase for Alzheimer’s research at the National Institutes of Health.

The human and financial toll of Alzheimer’s disease continues to grow. The Alzheimer’s Association 2018 Alzheimer’s Disease Facts and Figures report reveals that, for the second consecutive year, the total national cost of caring for people with Alzheimer’s and other dementias will exceed $277 billion in 2018.

On behalf of the families we work with every day, I want to thank Rep. Katko for his support and having the foresight to invest in research so that we can one day end this insidious disease.

Catherine James


James is chief executive officer of the Alzheimer’s Association, Central New York Chapter.


Be the first to know

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

Most Popular

Get up-to-the-minute news sent straight to your device.


News Alerts

Breaking News